BC LIONS V SASKATCHEWAN ROUGHRIDERS - GAME DAY youtu.be/ctyxLTk5d7Y?si=7fBh… via @YouTube via @RoughriderGuy69
#CFL #Riders #BCLions
1
1
2
913
May 28
⌇영상
🎥 2026 브랜드 고객충성도 대상 시상식 스케치 (2026년 가장 영향력있는 브랜드는?) 🏆
#김준수cut
youtu.be/rz6sXHq4i7c?si=djuC…
#2026브랜드고객충성도대상
#브랜드고객충성도대상 #BCLI
#시아준수 #준수 #XIA준수
#KIMJUNSU #XIA #XIAJUNSU
#ジュンス #金俊秀
9
30
506
May 26
$CNXU JUST HIT NASDAQ | REGENERATIVE MEDICINE WATCHLIST ALERT
Conexeu Sciences is now trading on Nasdaq under CNXU, advancing its proprietary CXU tissue regeneration platform.
Here's The Alpha:
🔹 Nasdaq listing milestone
🔹 Patented CXU ECM platform
🔹 B.R.E.A.S.T. 3D-bioprinted regenerative breast matrix
🔹 Ten Minute Tissue injectable ECM
Targeting wound care, aesthetics, GLP-1 tissue loss, periodontal care, biofabrication & vet markets
CNXU is positioning around a big idea: helping the body restore lost or damaged tissue, not just replace it. This is one to watch early. ⚡️
Communicated - Disclaimer:
stockresearchtoday.com/cnxu/
Sector Peers: $ORGO $MDXG $MDWD $HUMA $LCTX $KRYS $CAPR $BSEM $CELZ $PSTV $BCLI $AADI $TMDX $AXGN $IART $SNN $SYK $ZBH $EW $BSX $TNDM $NVRO $GKOS $CUTR $ISRG
2
33
6,313
May 22
Le registrazioni, alla stazione di massima PGA (Bacoli, BCLI) e quella a Napoli Fuorigrotta (NAFG), del terremoto di ieri ai Campi Flegrei (Md4.4).
[Dati @DPCgov , con l'aiuto di @robBaras]
[@UninaIT | @unipv | @eucentre | @ConsorzioReLUIS | @INGVterremoti]
3
6
324
May 19
Biotech Stock News 5/19 @ Open (1️⃣ of 2)
$EDSA 26% New Data on Paridiprubart
$RLAY 9% Initial clinical data for Zovegalisib
$BCLI 5% Aggregate of $400K in Placements
$TLSA 5% Positive Clinical Data for Foralumab
$ZBIO 4% Presentation of Obexelimab results
$WVE 2% Positive Update on WVE-006 Trial
$RHHBY 1% New data for Giredestrant in breast cancer
$INCY 1% Strategic Collaboration for AI Research
$LTRN 1% Successful FDA Meeting for LP-300
$LNTH 1% Presentation of Data at ASCO
$UTHR 1% TETON-1 Study of Tyvaso Published
$NKGN 0% Expands Clinical Trial Site Network
See the image and comments for more details! 👇
May 19
Relay Therapeutics’ first data readout for zovegalisib in a rare genetic disease beat Wall Street expectations, expanding the PI3Kα inhibitor’s R&D prospects beyond breast cancer. $RLAY
endpoints.news/relays-pi3k%C…
1
1
9
4,295
May 14
$CELZ COULD BE ONE CATALYST AWAY FROM A MAJOR MOMENTUM RE-RATE
Creative Medical is tightening right as CELZ-201-DDT Phase 2 results for chronic low-back pain are expected in May 2026.
Key levels on watch:
* Accumulation: $1.70–$1.82
* Reaccumulation: $2.02–$2.20
* Breakout: $2.32
* Major Resistance: $2.72
🎯 Target Zone: $3.31–$3.68
The roadmap is simple: hold $2.02–$2.20, reclaim $2.32, attack $2.72, then eyes on $3.31
With Phase 2 results potentially due any day now, volume confirmation could turn this setup from quiet accumulation into a serious catalyst-driven move.
Keep CELZ locked in.
Communicated - Disclaimer:
fh.bio/jcoop
Sector Peers: $VTGN $LCTX $ATHX $PSTV $BCLI $MESO $CAPR $CLSD $SLS $VSTM $TCRT $PLUR $OCX $PGEN $BLUE $CRSP $EDIT $NTLA $BEAM $FATE $VERV $RGEN $BPMC
1
11
4,255
May 4
🚨 93% RESPONSE RATE… AND $CELZ IS STILL UNDER THE RADAR
🧬 Ultrasome (derived from CELZ-201):
▪️ 93% response rate (pain mobility)
▪️ ZERO serious adverse events
▪️ Cell-free, off-the-shelf = scalable
💡 This is the shift:
Cell therapy ➝ mass-producible biologics
📊 THE SETUP
➝ Support: $1.20–$1.40
➝ Resistance: $1.75–$1.90
➝ Breakout: $2.00
➝ Targets: $2.50/ $3.00/ $4.00
📅 CATALYSTS
▪️ More clinical data
▪️ ADAPT trial updates
▪️ Partnerships / commercialization
⚠️ Multi-billion market scalable model strong data…
CELZ feels like early-stage price discovery
Watch this level closely 📣
Communicated - Disclaimer:
fh.bio/jcoop
Sector Peers: $CAPR $AUTL $MESO $LVRN $CYNAF $BCLI $PLX $MDXG $HUMA $KRON $REGN $ABBV $PFE $NVS $BMY
25
5,998
임영웅
'브랜드 고객충성도 대상’ 남자 광고모델 3년 연속 수상 응원합니다 대체불가 넘사벽 아티스트
#임영웅 #limyoungwoong
#2026브랜드고객충성도대상
#임영웅_남자광고모델수상 #BCLI
2
6
35
@follow_leejunho Big congrats from Spain, well deserve it! 👏👏🐧💛😘😘🥰
🏆 Premio a la Lealtad del Cliente de Marca 2026: Categoría de Actores Masculinos (Drama) 💐
#2026브랜드고객충성도대상 #브랜드고객충성도대상 #BCLI #이준호 #LEEJUNHO
@dlwnsghek
Apr 30
🏆 2026 브랜드 고객충성도 대상 🏆
<남자배우(드라마) 부문> 이준호
수상을 축하드립니다 💐
#2026브랜드고객충성도대상
#브랜드고객충성도대상 #BCLI
#이준호 #LEEJUNHO @dlwnsghek
2
11
308
May 1
[YouTube] BEHIND
김준수, 남다른 아우라 뽐낸 완벽 수트핏 "계속 도전할게요" [비하인드][4K] #김준수 #XIA
youtu.be/pAn0T9HBrmg?si=o7e_…
#2026브랜드고객충성도대상
#브랜드고객충성도대상 #BCLI
#시아준수 #준수 #KIMJUNSU #XIAJUNSU
#ジュンス #金俊秀
4
14
907
임영웅
2026 브랜드 고객충성도 대상
<광고모델(남) 부문> 수상 많이많이 추카추카 대체불가 빛나는 아티스트 #임영웅 #limyoungwoong
#2026브랜드고객충성도대상
#임영웅_남자광고모델수상 #BCLI
1
3
22
임영웅
2026 브랜드 고객충성도 대상
<광고모델(남) 부문> 수상 너무너무 축하축하 빛나는 아티스트 #임영웅 #limyoungwoong
#2026브랜드고객충성도대상
#임영웅_남자광고모델수상 #BCLI
1
2
20